AEGLEA BIOTHERAPEUTICS
Aeglea BioTherapeutics designs and develops human enzyme therapeutics for rare genetic diseases and cancer. Pegzilarginase, a recombinant human arginase 1 enzyme, is the company's product candidate now in clinical testing.
AEGLEA BIOTHERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2013-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.aeglea.com
Total Employee:
101+
Status:
Active
Contact:
+1 512 942 2935
Email Addresses:
[email protected]
Total Funding:
56 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 GoDaddy DNS Microsoft Gravity Forms AWS Global Accelerator WP Engine
Similar Organizations
Alethia BioTherapeutics
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Araim Pharmaceuticals
Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases.
Calidi Biotherapeutics
Calidi Biotherapeutics is a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
UT Horizon Fund
UT Horizon Fund investment in Series B - Aeglea BioTherapeutics
Lilly Ventures
Lilly Ventures investment in Series B - Aeglea BioTherapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - Aeglea BioTherapeutics
Jennison Associates
Jennison Associates investment in Series B - Aeglea BioTherapeutics
Ally Bridge Group
Ally Bridge Group investment in Series B - Aeglea BioTherapeutics
OrbiMed
OrbiMed investment in Series B - Aeglea BioTherapeutics
Venrock
Venrock investment in Series B - Aeglea BioTherapeutics
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - Aeglea BioTherapeutics
New Ground Ventures
New Ground Ventures investment in Series B - Aeglea BioTherapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Aeglea BioTherapeutics
Official Site Inspections
http://www.aeglea.com Semrush global rank: 2.35 M Semrush visits lastest month: 7.91 K
- Host name: afa7f374f51cc8991.awsglobalaccelerator.com
- IP address: 3.33.186.135
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
